Brief: Alzchem Confirms 2026 Forecast For Further Sales And EBITDA Growth
30/04/2026 05:59
April 30 (Reuters) - Alzchem Group AG ACT1.DE: EBITDA EUR 32.3 MILLION FORECAST 2026 FOR FURTHER SALES AND EBITDA GROWTH CONFIRMED Q1 2026 CONSOLIDATED SALES EUR 148.7 MILLION, UP 3% YEAR-ON-YEAR Q1 2026 EBITDA EUR 32.3 MILLION, MARGIN 21.7% VERSUS 18.9% PRIOR YEAR CONFIRMS 2026 FORECAST FOR FURTHER SALES AND EBITDA GROWTH Source text: ID:nEQ9PvBlqa Further company coverage: ACT1.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on AlzChem AG
See all newsGermany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group
Creamino Is Now Approved In EU For Use In Turkey Nutrition
Germany's Alzchem Group Q1 EBITDA, sales rise on specialty chemicals focus
Brief: Alzchem Confirms 2026 Forecast For Further Sales And EBITDA Growth